Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 411 articles:
HTML format
Text format



Single Articles


    October 2018
  1. MOLINA-LEYVA A, Badiola J
    Severe refractory hidradenitis suppurativa successfully treated with adalimumab in an HIV-positive/hepatitis C virus-positive patient.
    AIDS. 2018;32:2436-2438.
    PubMed     Text format    


  2. GAILLET A, Calin R, Imbert S, Ollivier M, et al
    Distinct paradoxical inflammatory reaction followed by postantiretroviral therapy immune reconstitution syndrome in cryptococcal meningitis.
    AIDS. 2018;32:2434-2436.
    PubMed     Text format    


  3. SCHIM VAN DER LOEFF MF
    Secondary anal cancer prevention in the HIV-infected: a step ahead but a long way to go.
    AIDS. 2018;32:2425-2427.
    PubMed     Text format    


  4. ROCKSTROH JK, Gonzalez-Scarano F
    Living donor liver transplant from an HIV-positive individual to an HIV-negative individual: could this become a new reality?
    AIDS. 2018;32:2423-2424.
    PubMed     Text format    


  5. BOTHA J, Conradie F, Etheredge H, Fabian J, et al
    Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options.
    AIDS. 2018;32:F13-F19.
    PubMed     Text format     Abstract available


  6. MCMILLAN J, Szlachetka A, Zhou T, Morsey B, et al
    Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002032.
    PubMed     Text format     Abstract available


  7. ROUL H, Mary-Krause M, Ghosn J, Delaugerre C, et al
    CD4 cell count recovery after combined antiretroviral therapy in the modern cART era.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002010.
    PubMed     Text format     Abstract available


  8. LAUT KG, Shepherd L, Gottfredsson M, Sedlacek D, et al
    Variation in antiretroviral treatment (ART) coverage and virological suppression among three HIV key populations.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002035.
    PubMed     Text format     Abstract available


  9. SUDFELD CR, Buchanan A, Ulenga N, Spiegelman D, et al
    Effectiveness of a multivitamin supplementation program among HIV-infected adults in Tanzania.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002033.
    PubMed     Text format     Abstract available


  10. MAJONGA ED, Rehman AM, Simms V, Mchugh G, et al
    High prevalence of echocardiographic abnormalities in older HIV-infected children taking antiretroviral therapy.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002031.
    PubMed     Text format     Abstract available


  11. STONER MCD, Nguyen N, Kilburn K, Gomez-Olive FX, et al
    Age-disparate partnerships and incident HIV infection in adolescent girls and young women in rural South Africa: An HPTN 068 analysis.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002037.
    PubMed     Text format     Abstract available


  12. GALAVIZ KI, Schneider MF, Tien P, Mehta CC, et al
    Predicting diabetes risk among HIV-positive and HIV-negative women: an assessment of the ADA and FINRISC diabetes risk scores.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002017.
    PubMed     Text format     Abstract available


  13. ERICKSON M, Shannon K, Sernick A, Pick N, et al
    Women, incarceration and HIV: a systematic review of HIV treatment access, continuity of care and health outcomes across incarceration trajectories.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002036.
    PubMed     Text format     Abstract available


  14. FORD ES, Magaret AS, Spak CW, Selke S, et al
    Increase in HSV shedding at initiation of antiretroviral therapy (ART) and decrease in shedding over time on ART in HIV and HSV-2 infected persons.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002002.
    PubMed     Text format     Abstract available


  15. SABIN CA, Harding R, Bagkeris E, Nkhoma K, et al
    Pain in people living with HIV and its association with healthcare resource use, well-being and functional status.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002021.
    PubMed     Text format     Abstract available


  16. MARUTHAMUTHU S, Raja R, Pandian K, Madasamy S, et al
    Inhibitory NK cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002028.
    PubMed     Text format     Abstract available


  17. CHOWDHURY FZ, Ouyang Z, Buzon M, Walker BD, et al
    Metabolic pathway activation distinguish transcriptional signatures of CD8+ T cells from HIV-1 elite controllers.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002007.
    PubMed     Text format     Abstract available


  18. VOURLI G, Pharris A, Cazein F, Costagliola D, et al
    Are European HIV cohort data within EuroCoord representative of the diagnosed HIV population?
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002034.
    PubMed     Text format     Abstract available


  19. LEAL L, Guardo AC, Moron-Lopez S, Salgado M, et al
    Phase I clinical trial of an intranodally administered mRNA based therapeutic vaccine against HIV-1 infection.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002026.
    PubMed     Text format     Abstract available


  20. ABRAMS EJ, Langwenya N, Gachuhi A, Zerbe A, et al
    Impact of universal ART for pregnant and postpartum women on ART uptake and retention.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002027.
    PubMed     Text format     Abstract available


  21. SUNDERMANN EE, Heaton RK, Pasipanodya E, Moore RC, et al
    Sex differences in HIV-associated cognitive impairment: an observational cohort study.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002012.
    PubMed     Text format     Abstract available


  22. NYAMATHI AM, Carpenter CL, Ekstrand ML, Yadav K, et al
    Randomized controlled trial of a community-based intervention on HIV and nutritional outcomes at six months among women living with HIV/AIDS in Rural India.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002016.
    PubMed     Text format     Abstract available


  23. LOHMANN S, White BX, Zuo Z, Chan MS, et al
    HIV messaging on twitter: an analysis of current practice and data-driven recommendations.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002018.
    PubMed     Text format     Abstract available


  24. DEBEAUDRAP P, Bodeau-Livinec F, Pasquier E, Germanaud D, et al
    Neurodevelopmental outcomes in HIV-infected and uninfected African children aged 4 to 9 years from the pediacam cohort.
    AIDS. 2018 Oct 4. doi: 10.1097/QAD.0000000000002023.
    PubMed     Text format     Abstract available


    September 2018

  25. High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years: Erratum.
    AIDS. 2018;32:2267.
    PubMed     Text format    


  26. JILG N, Hunt PW, Gandhi RT
    HIV DNA decay during antiretroviral therapy: lessons from a clinic-based cohort study.
    AIDS. 2018;32:2255-2257.
    PubMed     Text format    


  27. KOSS CA, Liu AY, Castillo-Mancilla J, Bacchetti P, et al
    Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoring.
    AIDS. 2018;32:2189-2194.
    PubMed     Text format     Abstract available


  28. NORET M, Balavoine S, Pintado C, Siguier M, et al
    Daily or on-demand oral tenofovir disoproxil fumarate/emtricitabine for HIV pre-exposure prophylaxis: experience from a hospital-based clinic in France.
    AIDS. 2018;32:2161-2169.
    PubMed     Text format     Abstract available


  29. HARTER ZJ, Agarwal S, Dalvi P, Voelkel NF, et al
    Drug abuse and HIV related pulmonary hypertension: double hit injury.
    AIDS. 2018 Sep 18. doi: 10.1097/QAD.0000000000002030.
    PubMed     Text format     Abstract available


  30. FORTHAL DN, Finzi A
    Antibody-Dependent Cellular Cytotoxicity (ADCC) in HIV Infection.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002011.
    PubMed     Text format    


  31. TAYLOR HE, Calantone NA, D'Aquila RT
    mTOR signaling mediates effects of common gamma-chain cytokines on T cell proliferation and exhaustion: implications for HIV-1 persistence and cure research.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000001997.
    PubMed     Text format     Abstract available


  32. KENYON C
    We need to consider collateral damage to resistomes when we decide how frequently to screen for chlamydia/gonorrhoea in PrEP cohorts.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002020.
    PubMed     Text format     Abstract available


  33. KELLER MJ, Burk RD, Massad LS, Eltoum IE, et al
    Racial differences in HPV types amongst US women with HIV and cervical precancer.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002005.
    PubMed     Text format     Abstract available


  34. BIBERT S, Wojtowicz A, Taffe P, Tarr PE, et al
    IFNL3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002004.
    PubMed     Text format     Abstract available


  35. ROHNER E
    Non-Hodgkin lymphoma risk in adults living with HIV across five continents: a multicohort study.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002003.
    PubMed     Text format     Abstract available


  36. SHAIYKOVA A, Pasquet A, Goujard C, Lion G, et al
    Reduced bone mineral density among HIV-infected, virologically controlled young men: Prevalence and associated factors.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002001.
    PubMed     Text format     Abstract available


  37. MZEMBE T, Mclean E, Khan PY, Koole O, et al
    Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002006.
    PubMed     Text format     Abstract available


  38. HARRINGTON BJ, Pence BW, Maliwichi M, Jumbe AN, et al
    Probable antenatal depression at antiretroviral initiation and postpartum viral suppression and engagement in Option B.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002025.
    PubMed     Text format     Abstract available


  39. LEECH AA, Burgess JF Jr, Sullivan M, Kuohung W, et al
    Cost-effectiveness of pre-exposure prophylaxis for HIV prevention for conception in the United States.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002014.
    PubMed     Text format     Abstract available


  40. HOARE J, Fouche JP, Phillips N, Joska JA, et al
    Structural brain changes in perinatally HIV infected young adolescents in South Africa.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002024.
    PubMed     Text format     Abstract available


  41. BANDERA A, Colella E, Clerici M, Rizzardini G, et al
    The contribution of immune activation and accelerated aging in multiple myeloma occurring in HIV-infected population.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002015.
    PubMed     Text format     Abstract available


  42. LUO Z, Ogunrinde E, Li M, Zhang L, et al
    Increased influenza-specific antibody avidity in HIV-infected females compared to HIV-infected males on antiretroviral therapy.
    AIDS. 2018 Sep 17. doi: 10.1097/QAD.0000000000002022.
    PubMed     Text format     Abstract available


  43. EMONTS M, Waalewijn H, Colbers A, Pickering A, et al
    First reported use of zidovudine for prevention of perinatal HIV transmission in a premature neonate on extra corporal membrane oxygenation.
    AIDS. 2018;32:2084-2085.
    PubMed     Text format    


  44. BURGESS PI, Harding SP, Kayange PC, van Oosterhout J, et al
    High mortality in subjects with both diabetes and HIV in sub-Saharan Africa.
    AIDS. 2018;32:2083-2084.
    PubMed     Text format    


  45. SHARMA P, McCarty TR, Ngu JN, O'Donnell M, et al
    Impact of bariatric surgery in patients with HIV infection: a nationwide inpatient sample analysis, 2004-2014.
    AIDS. 2018;32:1959-1965.
    PubMed     Text format     Abstract available


    August 2018

  46. Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals: Erratum.
    AIDS. 2018;32:1911.
    PubMed     Text format    



  47. Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients: Erratum.
    AIDS. 2018;32:1909-1910.
    PubMed     Text format    


  48. PAPASAVVAS E, Lada SM, Joseph J, Yin X, et al
    Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.
    AIDS. 2018;32:1763-1772.
    PubMed     Text format     Abstract available


  49. TCHAKOUTE CT, Sainani KL, Osawe S, Datong P, et al
    Breastfeeding mitigates the effects of maternal HIV on infant infectious morbidity in the Option B+ era: A multicenter prospective cohort study.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001974.
    PubMed     Text format     Abstract available


  50. ERLANDSON KM, MaWhinney S, Wilson M, Gross L, et al
    Physical function improvements with moderate or high-intensity exercise among older adults with or without HIV infection.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001984.
    PubMed     Text format     Abstract available


  51. DAVY-MENDEZ T, Eron JJ, Brunet L, Zakharova O, et al
    New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001990.
    PubMed     Text format     Abstract available


  52. MOMPER JD, Best BM, Wang J, Capparelli EV, et al
    Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001992.
    PubMed     Text format     Abstract available


  53. PELCHEN-MATTHEWS A, Ryom L, Borges AH, Edwards S, et al
    Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001967.
    PubMed     Text format     Abstract available


  54. WANG R, Haberlen SA, Palella FJ Jr, Mugavero MJ, et al
    Viremia copy-years and mortality among cART-initiating HIV-positive individuals: how much viral load history is enough?
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001986.
    PubMed     Text format     Abstract available


  55. SHADE SB, Osmand T, Luo A, Aine R, et al
    Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the search study.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001958.
    PubMed     Text format     Abstract available


  56. MILANINI B, Paul R, Bahemana E, Adamu Y, et al
    Limitations of the international HIV dementia scale in the current era.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001968.
    PubMed     Text format     Abstract available


  57. PISKE M, Budd MA, Qiu AQ, Maan EJ, et al
    Neurodevelopmental outcomes and in utero antiretroviral exposure in HIV-exposed uninfected children.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001985.
    PubMed     Text format     Abstract available


  58. KALAYJIAN RC, Albert JM, Cremers S, Gupta SK, et al
    Women have enhanced bone loss associated with phosphaturia and CD4 cell restoration during initial antiretroviral therapy.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001995.
    PubMed     Text format     Abstract available


  59. KANTOR R, Delong A, Schreier L, Reitsma M, et al
    HIV Second-Line Failure and Drug Resistance at High- and Low-Level Viremia in Western Kenya.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001964.
    PubMed     Text format     Abstract available


  60. VAN DER HEIJDEN WA, van Crevel R, De Groot PG, Urbanus RT, et al
    A Switch to a raltegravir containing regimen does not lower platelet reactivity in HIV-infected individuals.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001993.
    PubMed     Text format     Abstract available


  61. SHADE SB, Osmand T, Luo A, Aine R, et al
    Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the search study.
    AIDS. 2018 Aug 20. doi: 10.1097/QAD.0000000000001958.
    PubMed     Text format     Abstract available


  62. COSTINIUK CT, Salahuddin S, Farnos O, Olivenstein R, et al
    HIV persistence in mucosal CD4+ T-cells within the lungs of adults receiving long-term suppressive antiretroviral therapy.
    AIDS. 2018 Aug 14. doi: 10.1097/QAD.0000000000001962.
    PubMed     Text format     Abstract available


  63. CUI H, Geng W, Sun H, Han X, et al
    Rapid CD4+ T-cell decline is associated with coreceptor switch among men who have sex with men primarily infected with HIV-1 CRF01_AE in Northeast China.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001981.
    PubMed     Text format     Abstract available


  64. MIZUNO Y, Higa DH, Leighton CA, Roland KB, et al
    Is HIV patient navigation associated with HIV care continuum outcomes? A systematic review.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001987.
    PubMed     Text format     Abstract available


  65. WILLIAMS PL, Correia K, Karalius B, Van Dyke RB, et al
    Cardiac status of perinatally HIV-infected children: assessing combination antiretroviral regimens in observational studies.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001988.
    PubMed     Text format     Abstract available


  66. GRAY ER, Bain R, Varsaneux O, Peeling RW, et al
    p24 revisited: A landscape review of antigen detection for early HIV diagnosis.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001982.
    PubMed     Text format     Abstract available


  67. RAYMOND S, Delaugerre C, Nicot F, Assoumou L, et al
    Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001976.
    PubMed     Text format     Abstract available


  68. HANNA DB, Moon JY, Haberlen SA, French AL, et al
    Carotid artery atherosclerosis is associated with mortality in hiv-positive women and men.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001972.
    PubMed     Text format     Abstract available


  69. PATEL K, Lindsey J, Angelidou K, Aldrovandi G, et al
    Metabolic effects of initiating lopinavir/ritonavir-based regimens among young children: 7-year follow-up of the IMPAACT P1060 trial.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001980.
    PubMed     Text format     Abstract available


  70. KOEHN J, Iwamoto JF, Kraft JC, McCONNACHIE LA, et al
    Extended cell and plasma drug levels after one dose of a 3-in-1 nanosuspension containing lopinavir, efavirenz, and tenofovir in non-human primates.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001969.
    PubMed     Text format     Abstract available


  71. ANTONIO MB, Cuba GT, Vasconcelos RP, Alves APPS, et al
    Natural experiment of syphilis treatment with doxycycline or benzathine penicillin in HIV-infected patients.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001975.
    PubMed     Text format     Abstract available


  72. MOLLOY SF, Bradley J, Karunaharan N, Mputu M, et al
    Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis.
    AIDS. 2018 Aug 9. doi: 10.1097/QAD.0000000000001961.
    PubMed     Text format     Abstract available


  73. ZHANG X, Ding X, Zhu Y, Chong H, et al
    Structural and functional characterization of HIV-1 cell fusion inhibitor T20.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001979.
    PubMed     Text format     Abstract available


  74. NUNEZ O, Hernando V, Diaz A
    Estimating the number of people living with HIV and the undiagnosed fraction in Spain in 2013.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001989.
    PubMed     Text format     Abstract available


  75. LLEDO GM, Carrasco I, Benitez-Gutierrez LM, Arias A, et al
    Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001966.
    PubMed     Text format     Abstract available


  76. KAMITANI E, Wichser ME, Adegbite AH, Mullins MM, et al
    Increasing prevalence of self-reported HIV pre-exposure prophylaxis (PrEP) use in published surveys - a systematic review and meta-analysis.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001983.
    PubMed     Text format     Abstract available


  77. PRICE JC, Seaberg EC, Stosor V, Witt MD, et al
    AST-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001977.
    PubMed     Text format     Abstract available


  78. COLIN DE VERDIERE N, Durier C, Samri A, Meiffredy V, et al
    Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001963.
    PubMed     Text format     Abstract available


  79. DELAUGERRE C, Rodriguez C, Capitant C, Nere ML, et al
    Drug resistance among patients who acquired HIV infection in a PrEP trial.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001960.
    PubMed     Text format     Abstract available


  80. SHIBOSKI CH, Yao TJ, Russell JS, Ryder MI, et al
    The association between oral disease and type of antiretroviral therapy among perinatally HIV-Infected youth.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001965.
    PubMed     Text format     Abstract available


  81. KROON E, Pham PT, Sirivichayakul S, Trichavaroj R, et al
    Transmission dynamics among participants initiating anti-retroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001956.
    PubMed     Text format     Abstract available


  82. RHINES AS, Feldman MW, Bendavid E
    Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001959.
    PubMed     Text format     Abstract available


    July 2018
  83. ROSSOTTI R, Maggioni M, Merli M, Orcese C, et al
    Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject.
    AIDS. 2018;32:1727-1729.
    PubMed     Text format    


  84. VERMUND SH, Kelley KF
    Impact of HIV on human papilloma virus-mediated cervical disease progression.
    AIDS. 2018;32:1715-1717.
    PubMed     Text format    


  85. MASABA R, Borkowf CB, Girde S, Zeh C, et al
    Adverse fetal and infant outcomes among HIV-infected women who received either nonnucleoside reverse transcriptase inhibitor-based or protease inhibitor-based antiretroviral therapy for prevention of mother-to-child transmission.
    AIDS. 2018;32:1625-1632.
    PubMed     Text format     Abstract available


  86. BRUMME ZL, Kinloch NN, Sanche S, Wong A, et al
    Extensive host immune adaptation in a concentrated North American HIV epidemic.
    AIDS. 2018 Jul 25. doi: 10.1097/QAD.0000000000001912.
    PubMed     Text format     Abstract available


  87. SARAIYA N, Kanagala V, Corpuz M
    HIV-2 in the United States: rare but not forgotten.
    AIDS. 2018;32:1547-1549.
    PubMed     Text format    


  88. SCHMIDT B
    The Fab-ulous IgM in neutralizing HIV-1.
    AIDS. 2018;32:1535-1536.
    PubMed     Text format    


  89. LACOMBE K
    Risk of hepatocellular carcinoma after DAA treatment in cirrhotic HIV-HCV-coinfected patients: where do we stand?
    AIDS. 2018;32:1533-1534.
    PubMed     Text format    


  90. MONTGOMERY ET, Stadler J, Naidoo S, Katz AWK, et al
    Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.
    AIDS. 2018;32:1517-1525.
    PubMed     Text format     Abstract available


  91. MUSINGUZI N, Muwonge T, Ngure K, Katabira E, et al
    Comparison of SMS self-reported adherence with other adherence measures in a demonstration project of HIV pre-exposure prophylaxis in Kenya and Uganda.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001955.
    PubMed     Text format     Abstract available


  92. LIU Y, Blakely M, Sigel K, Thin TH, et al
    Biomarker P16 predicts progression risk of anal low-grade squamous intraepithelial lesions.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001957.
    PubMed     Text format     Abstract available


  93. HARSLOF M, Knudsen AD, Benfield T, Nordestgaard BG, et al
    No evidence of increased risk of thyroid dysfunction in well-treated people living with HIV.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001954.
    PubMed     Text format     Abstract available


  94. GORRY PR, Ahmad F, Mohl J, Alkhatib G, et al
    Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001953.
    PubMed     Text format     Abstract available


  95. KELLY H, Chikandiwa A, Warman R, Segondy M, et al
    Associations of human gene EPB41L3 DNA methylation and cervical intraepithelial neoplasia in women living with HIV-1 in Africa.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001932.
    PubMed     Text format     Abstract available


  96. DUARTE HA, Beck IA, Levine M, Kiptinness C, et al
    Implementation of a point mutation assay for HIV drug resistance testing in Kenya: performance, challenges, and cost.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001934.
    PubMed     Text format     Abstract available


  97. KOSS CA, Liu AY, Castillo-Mancilla J, Bacchetti P, et al
    Similar tenofovir hair concentrations in men and women after directly-observed: dosing of TDF/FTC: implications for PrEP adherence monitoring.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001935.
    PubMed     Text format     Abstract available


  98. LEE H, Wu XK, Genberg BL, Mugavero MJ, et al
    Beyond binary retention in HIV care: Predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001936.
    PubMed     Text format     Abstract available


  99. CHANG CC, Naranbhai V, Stern J, Roche M, et al
    Variation in cell associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator BMAL-1.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001937.
    PubMed     Text format     Abstract available


  100. ORTEGA PAS, Saulle I, Mercurio V, Ibba SV, et al
    The interleukin 21 (IL 21)/ microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001938.
    PubMed     Text format     Abstract available


  101. NORET M, Balavoine S, Noret M, Pintado C, et al
    Daily or on demand oral TDF/FTC for HIV pre-exposure prophylaxis: experience from an hospital-based clinic in France.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001939.
    PubMed     Text format     Abstract available


  102. WORODRIA W, Ssempijja V, Hanrahan C, Ssegonja R, et al
    Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ counts.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001941.
    PubMed     Text format     Abstract available


  103. MSUKWA MT, Estill J, Haas AD, van Oosterhout JJ, et al
    Weight gain of HIV-exposed, uninfected children born before and after introduction of the "Option B+" programme in Malawi.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001942.
    PubMed     Text format     Abstract available


  104. HUNTER MD, Shenoy A, Dwork A, Elkind MSV, et al
    Brain vascular intima vulnerability among HIV-positive and negative individuals.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001943.
    PubMed     Text format     Abstract available


  105. LAHIRI CD, Brown NL, Ryan KJ, Acosta EP, et al
    HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapy.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001945.
    PubMed     Text format     Abstract available


  106. MATSON TE, Mcginnis KA, Rubinsky AD, Frost MC, et al
    Gender and alcohol use: influences on HIV care continuum in a national cohort of patients with HIV.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001946.
    PubMed     Text format     Abstract available


  107. CLIFFORD GM, Siproudhis L, Piroth L, Poizot-Martin I, et al
    Determinants of high-grade anal intraepithelial lesions in HIV-positive men having sex with men.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001947.
    PubMed     Text format     Abstract available


  108. GOLOB JL, Stern J, Holte S, Kitahata MM, et al
    HIV DNA levels and decay in a cohort of 111 long-term virally suppressed patients.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001948.
    PubMed     Text format     Abstract available


  109. ULFHAMMER G, Eden A, Mellgren A, Fuchs D, et al
    Persistent CNS immune activation following > 10 years of effective HIV antiretroviral treatment.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001950.
    PubMed     Text format     Abstract available


  110. ADZHUBEI AA, Anashkina AA, Tkachev YV, Kravatsky YV, et al
    Modelling interaction between HIV-1 Nef and calnexin.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001951.
    PubMed     Text format     Abstract available


  111. FICHT AL, Komba A, Bisimba J, Mlanga E, et al
    The time is now: closing the pediatric treatment gap and building resilience among female sex workers and their children.
    AIDS. 2018 Jul 12. doi: 10.1097/QAD.0000000000001952.
    PubMed     Text format     Abstract available


  112. VORKOPER S, Kupfer LE, Anand N, Patel P, et al
    Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda.
    AIDS. 2018;32 Suppl 1:S107-S113.
    PubMed     Text format     Abstract available


  113. KEMP CG, Weiner BJ, Sherr KH, Kupfer LE, et al
    Implementation science for integration of HIV and non-communicable disease services in sub-Saharan Africa: a systematic review.
    AIDS. 2018;32 Suppl 1:S93-S105.
    PubMed     Text format     Abstract available


  114. NUGENT R, Barnabas RV, Golovaty I, Osetinsky B, et al
    Costs and cost-effectiveness of HIV/noncommunicable disease integration in Africa: from theory to practice.
    AIDS. 2018;32 Suppl 1:S83-S92.
    PubMed     Text format     Abstract available


  115. JOHNSON M, Wilkinson J, Gardner A, Kupfer LE, et al
    Global partnerships to support noncommunicable disease care in low and middle-income countries: lessons from HIV/AIDS.
    AIDS. 2018;32 Suppl 1:S75-S82.
    PubMed     Text format     Abstract available


  116. JUMA K, Reid M, Roy M, Vorkoper S, et al
    From HIV prevention to non-communicable disease health promotion efforts in sub-Saharan Africa: A Narrative Review.
    AIDS. 2018;32 Suppl 1:S63-S73.
    PubMed     Text format     Abstract available


  117. PASTAKIA SD, Tran DN, Manji I, Wells C, et al
    Building reliable supply chains for noncommunicable disease commodities: lessons learned from HIV and evidence needs.
    AIDS. 2018;32 Suppl 1:S55-S61.
    PubMed     Text format     Abstract available


  118. RABKIN M, de Pinho H, Michaels-Strasser S, Naitore D, et al
    Strengthening the health workforce to support integration of HIV and noncommunicable disease services in sub-Saharan Africa.
    AIDS. 2018;32 Suppl 1:S47-S54.
    PubMed     Text format     Abstract available


  119. RABKIN M, Palma A, McNairy ML, Gachuhi AB, et al
    Integrating cardiovascular disease risk factor screening into HIV services in Swaziland: lessons from an implementation science study.
    AIDS. 2018;32 Suppl 1:S43-S46.
    PubMed     Text format     Abstract available


  120. NJUGUNA B, Vorkoper S, Patel P, Reid MJA, et al
    Models of integration of HIV and noncommunicable disease care in sub-Saharan Africa: lessons learned and evidence gaps.
    AIDS. 2018;32 Suppl 1:S33-S42.
    PubMed     Text format     Abstract available


  121. MATANJE MWAGOMBA BL, Ameh S, Bongomin P, Juma PA, et al
    Opportunities and challenges for evidence-informed HIV-noncommunicable disease integrated care policies and programs: lessons from Malawi, South Africa, Swaziland and Kenya.
    AIDS. 2018;32 Suppl 1:S21-S32.
    PubMed     Text format     Abstract available


  122. PATEL P, Rose CE, Collins PY, Nuche-Berenguer B, et al
    Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.
    AIDS. 2018;32 Suppl 1:S5-S20.
    PubMed     Text format     Abstract available


  123. EL-SADR WM, Goosby E
    Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV.
    AIDS. 2018;32 Suppl 1:S1-S3.
    PubMed     Text format     Abstract available


  124. HEFFRON R, Mugo N, Hong T, Celum C, et al
    Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention.
    AIDS. 2018;32:1707-1713.
    PubMed     Text format     Abstract available


    June 2018
  125. MENDOZA MCB, Gardner L, Armon C, Rose C, et al
    Time spent with HIV viral load >1500 copies/mL among patients in HIV care, 2000-2014.
    AIDS. 2018 Jun 28. doi: 10.1097/QAD.0000000000001921.
    PubMed     Text format     Abstract available


  126. GRAYHACK C, Sheth A, Kirby O, Davis J, et al
    Evaluating outcomes of mother-infants pairs using dolutegravir for HIV treatment during pregnancy.
    AIDS. 2018 Jun 25. doi: 10.1097/QAD.0000000000001931.
    PubMed     Text format     Abstract available


  127. CHAMPENOIS K, Seng R, Persoz A, Essat A, et al
    Recent trends in sexual behaviours among MSM followed since primary HIV-1 infection.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001916.
    PubMed     Text format     Abstract available


  128. BERETTA M, Moreau A, Bouvin-Pley M, Essat A, et al
    Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001906.
    PubMed     Text format     Abstract available


  129. HOY JF, Richardson R, Ebeling PR, Rojas J, et al
    Zoledronic acid is superior to tenofovir DF-switching for low bone mineral density in adults with HIV: a randomised trial.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001911.
    PubMed     Text format     Abstract available


  130. SIMMS V, Rylance S, Bandason T, Dauya E, et al
    CD4 count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence.
    AIDS. 2018 Jun 20. doi: 10.1097/QAD.0000000000001905.
    PubMed     Text format     Abstract available


  131. AHMAD A, Mehraj V, Jenabian MA, Routy JP, et al
    Anti-Gag antibodies gag HIV infection and slow disease progression.
    AIDS. 2018;32:1373-1375.
    PubMed     Text format    


  132. ROBBINS HA
    Lung cancer screening in people living with HIV: modeling to bridge the evidence.
    AIDS. 2018;32:1369-1371.
    PubMed     Text format    


  133. HUGHES RA, May MT, Tilling K, Taylor N, et al
    Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio.
    AIDS. 2018;32:1361-1367.
    PubMed     Text format     Abstract available


  134. PRESTI RM, Handley SA, Droit L, Ghannoum M, et al
    Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status.
    AIDS. 2018;32:1279-1287.
    PubMed     Text format     Abstract available


  135. KOUYOUMJIAN SP, Heijnen M, Chaabna K, Mumtaz GR, et al
    Global population-level association between herpes simplex virus 2 prevalence and HIV prevalence.
    AIDS. 2018;32:1343-1352.
    PubMed     Text format     Abstract available


  136. HAWKINS KL, Zhang L, Ng DK, Althoff KN, et al
    Abdominal obesity, sarcopenia, and osteoporosis are associated with frailty in men living with and without HIV.
    AIDS. 2018;32:1257-1266.
    PubMed     Text format     Abstract available


  137. ZHANG Y, Fogel JM, Guo X, Clarke W, et al
    Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa.
    AIDS. 2018;32:1301-1306.
    PubMed     Text format     Abstract available


  138. ATTIA EF, Maleche-Obimbo E, West TE, Ndukwe-Wambutsi L, et al
    Adolescent age is an independent risk factor for abnormal spirometry among people living with HIV in Kenya.
    AIDS. 2018;32:1353-1359.
    PubMed     Text format     Abstract available


  139. HU J, Geldsetzer P, Steele SJ, Matthews P, et al
    The impact of lay counselors on HIV testing rates: Quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South Africa.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001924.
    PubMed     Text format     Abstract available


  140. SAXENA V, Ghate M, Bichare S, Khan I, et al
    Increased degranulation of immune cells is associated with higher cervical viral load in HIV infected women.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001925.
    PubMed     Text format     Abstract available


  141. RUEGAMER T, Hoffmann R, Rohrhofer A, Audebert F, et al
    Inhibition of HIV-1 infection by HPgV-1 derived peptides is affected by HPgV-1 genotype and HIV-1 coreceptor tropism.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001926.
    PubMed     Text format     Abstract available


  142. SOONTORNNIYOMKIJ V, Umlauf A, Soontornniyomkij B, Gouaux B, et al
    Association of antiretroviral therapy with brain aging changes among HIV-infected adults.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001927.
    PubMed     Text format     Abstract available


  143. PETERS L, Laut K, Resnati C, Del Campo S, et al
    Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001928.
    PubMed     Text format     Abstract available


  144. RUBIN LH, Phan KL, Keating SM, Maki PM, et al
    A single low-dose of hydrocortisone enhances cognitive functioning in HIV-infected women.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001930.
    PubMed     Text format     Abstract available


  145. CHHABRA S, Underwood J, Cole JH, Caan M, et al
    Clinical research cerebral MRI findings in HIV positive subjects and appropriate controls.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001910.
    PubMed     Text format     Abstract available


  146. VALVERDE EE, Beer L, Johnson CH, Baugher A, et al
    Changes in perceived discrimination in healthcare settings reported by HIV patients in the United States from 1996 to 2011-2013.
    AIDS. 2018 Jun 14. doi: 10.1097/QAD.0000000000001908.
    PubMed     Text format     Abstract available


  147. DE LEOTOING L, Yazdanpanah Y, Finkielsztejn L, Chaize G, et al
    Costs Associated with Hospitalisation in Hiv-Positive Patients in France.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001907.
    PubMed     Text format     Abstract available


  148. DE NEVE JW, Karlsson O, Coetzee L, Schroder H, et al
    Antiretroviral therapy coverage associated with increased co-residence between elderly people and prime-age adults in Africa.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001917.
    PubMed     Text format     Abstract available


  149. OSMAN N, Mesplede T, Oliveira M, Hassounah S, et al
    Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001903.
    PubMed     Text format     Abstract available


  150. PAPASAVVAS E, Lada SM, Joseph J, Yin X, et al
    Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001909.
    PubMed     Text format     Abstract available


  151. D'ELBEE M, Indravudh PP, Mwenge L, Kumwenda MM, et al
    Preferences for linkage to HIV care services following a reactive self-test: discrete choice experiments in Malawi and Zambia.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001918.
    PubMed     Text format     Abstract available


  152. PYRA M, Anderson PL, Hendrix CW, Heffron R, et al
    Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral pre-exposure prophylaxis.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001922.
    PubMed     Text format     Abstract available


  153. HUGHES AJ, Rector A, Jimenez V, Brock J, et al
    Cumulative plasma HIV burden disparities among adults in HIV care: implications for HIV transmission in the era of treatment as prevention.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001914.
    PubMed     Text format     Abstract available


  154. SEATLA KK, Avalos A, Moyo S, Mine M, et al
    Four class drug resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir based antiretroviral therapy in Botswana.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001920.
    PubMed     Text format     Abstract available


  155. XIA Q, Abraham B, Shah D, Ramaswamy C, et al
    Transition from pediatric to adult care among persons with perinatal HIV infection in New York City, 2006-2015.
    AIDS. 2018 Jun 11. doi: 10.1097/QAD.0000000000001923.
    PubMed     Text format     Abstract available


  156. DIJKSTRA M, van Lunsen RHW, Kooij KW, Davidovich U, et al
    HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy.
    AIDS. 2018;32:1137-1146.
    PubMed     Text format     Abstract available


  157. CHOW FC, Wilson MR, Wu K, Ellis RJ, et al
    Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort.
    AIDS. 2018;32:1125-1135.
    PubMed     Text format     Abstract available


    May 2018
  158. SHAPIRO AE, Hong T, Govere S, Thulare H, et al
    C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001902.
    PubMed     Text format     Abstract available


  159. WOOLNOUGH EL, Hoy JF, Cheng AC, Walker RG, et al
    Predictors of chronic kidney disease and utility of risk prediction scores in HIV positive individuals.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001901.
    PubMed     Text format     Abstract available


  160. RONIT A, Hatleberg CI, Ryom L, Bonnet F, et al
    Associations between serum albumin and serious non-AIDS events among people living with HIV.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001900.
    PubMed     Text format     Abstract available


  161. MILLS EJ, Adhvaryu A, Jakiela P, Birungi J, et al
    Unconditional cash transfers for clinical and economic outcomes among HIV-affected Ugandan households: a bayesian randomised trial.
    AIDS. 2018 May 28. doi: 10.1097/QAD.0000000000001899.
    PubMed     Text format     Abstract available


  162. JAFFE HW
    Lessons from the early HIV/AIDS epidemic.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001877.
    PubMed     Text format    


  163. KOLBER MA
    HIV solid organ transplantation: looking beyond HOPE.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001892.
    PubMed     Text format    


  164. SIEDNER MJ, Hettema A, Hughey A, Oldenburg CE, et al
    Preference for injectable over oral HIV pre-exposure prophylaxis in public-sector primary-care clinics in Swaziland.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001859.
    PubMed     Text format     Abstract available


  165. LE ROUX S, Donald K, Brittain K, Phillips TK, et al
    Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa: a prospective cohort.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001872.
    PubMed     Text format     Abstract available


  166. GLESBY MJ, Hanna DB, Hoover DR, Shi Q, et al
    Abdominal fat depots, insulin resistance, and incident diabetes mellitus in women with and without HIV infection.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001873.
    PubMed     Text format     Abstract available


  167. WU M, Fatukasi O, Yang S, Alger J, et al
    HIV disease and diabetes interact to affect brain white matter hyperintensities and cognition.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001891.
    PubMed     Text format     Abstract available


  168. BARTLETT AW, Khanh TH, Songtaweesin WN, Chokephaibulkit K, et al
    Characteristics, mortality and outcomes at transition for adolescents with perinatal HIV infection in Asia.
    AIDS. 2018 May 22. doi: 10.1097/QAD.0000000000001883.
    PubMed     Text format     Abstract available


  169. LINDGREN AA, Filipowicz AR, Hattler JB, Kim SO, et al
    Lentiviral infection of proliferating brain macrophages in HIV and simian immunodeficiency virus encephalitis despite sterile alpha motif and histidine-aspartate domain-containing protein 1 expression.
    AIDS. 2018;32:965-974.
    PubMed     Text format     Abstract available


  170. MOLSBERRY SA, Cheng Y, Kingsley L, Jacobson L, et al
    Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001865.
    PubMed     Text format     Abstract available


  171. KILBURN K, Ranganathan M, Stoner MCD, Hughes JP, et al
    Transactional sex and incident HIV infection in a cohort of young women from rural South Africa enrolled in HPTN 068.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001866.
    PubMed     Text format     Abstract available


  172. HEFFRON R, Mugo N, Hong T, Celum C, et al
    Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001867.
    PubMed     Text format     Abstract available


  173. MONTGOMERY ET, Stadler J, Naidoo S, Katz A, et al
    Reasons for non-adherence to the dapivirine vaginal ring: results of the MTN-032/ AHA study.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001868.
    PubMed     Text format     Abstract available


  174. KONG D, Wang Y, Ji P, Li W, et al
    A defucosylated bispecific multivalent molecule exhibits broad HIV-1 neutralizing activity and enhanced ADCC against reactivated HIV-1 latently infected cells.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001869.
    PubMed     Text format     Abstract available


  175. HARRIS TG, Rabkin M, El-Sadr WM
    Achieving the 4th 90 - Healthy Aging for People Living with HIV.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001870.
    PubMed     Text format    


  176. WOODSON E, Goldberg A, Michelo C, Basu D, et al
    HIV transmission in Discordant Couples in Africa in the context of ART availability.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001871.
    PubMed     Text format     Abstract available


  177. DILLON SM, Guo K, Austin GL, Gianella S, et al
    A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001863.
    PubMed     Text format     Abstract available


  178. HOORNENBORG E, Coyer L, van Laarhoven A, Achterbergh R, et al
    Change in sexual risk behaviour after six months of pre-exposure prophylaxis use: results from the Amsterdam PrEP demonstration project.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001874.
    PubMed     Text format     Abstract available


  179. DUFFAU P, Ozanne A, Bonnet F, Lazaro E, et al
    Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001875.
    PubMed     Text format     Abstract available


  180. ALUISIO AR, Palaniappan A, Farquhar C, Mello MJ, et al
    Integrated HIV-injury programming: An underutilized intersection to engage young adults in HIV care in low- and middle-income countries.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001876.
    PubMed     Text format     Abstract available


  181. MOYO S, Gaseitsiwe S, Powis KM, Pretorius Holme M, et al
    Undisclosed antiretroviral drug use in Botswana: implication for national estimates.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001862.
    PubMed     Text format     Abstract available


  182. YANG J, Sharma A, Shi Q, Anastos K, et al
    Improved fracture prediction using different FRAX adjustments in HIV-infected women.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001864.
    PubMed     Text format     Abstract available


  183. BARNES A, Betts AC, Borton EK, Sanders JM, et al
    Cervical cancer screening among HIV infected women in an urban, U.S. safety-net healthcare system.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001881.
    PubMed     Text format     Abstract available


  184. TSUKAMOTO T
    Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001882.
    PubMed     Text format     Abstract available


  185. WINCKELMANN A, Morcilla V, Shao W, Schleimann MH, et al
    Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001861.
    PubMed     Text format     Abstract available


  186. GONG S, Tomusange K, Kulkarni V, Adeniji OS, et al
    Anti-HIV IgM protects against mucosal SHIV transmission.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001857.
    PubMed     Text format     Abstract available


  187. CICHOWITZ C, Watt MH, Mmbaga BT
    Childbirth experiences of women living with HIV: a neglected event in the prevention of mother-to-child transmission care continuum.
    AIDS. 2018 May 11. doi: 10.1097/QAD.0000000000001860.
    PubMed     Text format    


  188. RUBIN LH, Sacktor N, Creighton J, Du Y, et al
    Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001858.
    PubMed     Text format     Abstract available


  189. EVANS VA, Van Der Sluis RM, Solomon A, Dantanarayana A, et al
    PD-1 contributes to the establishment and maintenance of HIV-1 latency.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001849.
    PubMed     Text format     Abstract available


  190. VITORIA M, Hill A, Ford N, Doherty M, et al
    The transition to dolutegravir and other new antiretrovirals in low- and middle-income countries - what are the issues?
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001845.
    PubMed     Text format     Abstract available


  191. ROJAS J, Blanco JL, Sanchez-Palomino S, Marcos MA, et al
    A maintenance three-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity: the A-TRI-WEEK pilot trial.
    AIDS. 2018 May 9. doi: 10.1097/QAD.0000000000001843.
    PubMed     Text format     Abstract available


  192. JANI IV, Meggi B, Loquiha O, Tobaiwa O, et al
    Effect of point-of-care early infant diagnosis on antiretroviral therapy initiation and retention of patients: a cluster-randomised trial.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001846.
    PubMed     Text format     Abstract available


  193. YANG J, Jacobson LP, Becker JT, Levine A, et al
    Impact of glycemic status on longitudinal cognitive performance in men with and without HIV Infection.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001842.
    PubMed     Text format     Abstract available


  194. CARLANDER C, Wagner P, Beirs AV, Yilmaz A, et al
    Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001853.
    PubMed     Text format     Abstract available


  195. HORVATH S, Phillips N, Heany SJ, Kobor MS, et al
    Perinatally acquired HIV infection accelerates epigenetic aging in South African adolescents.
    AIDS. 2018 May 8. doi: 10.1097/QAD.0000000000001854.
    PubMed     Text format     Abstract available


  196. MANICKAM C, Nwanze C, Ram DR, Shah SV, et al
    Progressive lentivirus infection induces natural killer cell receptor-expressing B cells in the gastrointestinal tract.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001855.
    PubMed     Text format     Abstract available


  197. HUGHES RA, May MT, Tilling K, Taylor N, et al
    Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001848.
    PubMed     Text format     Abstract available


  198. ADLAND E, Mori L, Laker L, Csala A, et al
    Recovery of effective hiv-specific cd4+ t-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001844.
    PubMed     Text format     Abstract available


  199. INVERNIZZI A, Acquistapace A, Bochicchio S, Resnati C, et al
    Correlation between inner retinal layer thickness and cognitive function in HIV: new insights from an exploratory study.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001850.
    PubMed     Text format     Abstract available


  200. KORHONEN C, Kimani M, Wahome E, Otieno F, et al
    Depressive symptoms and problematic alcohol and other substance use in 1,476 gay, bisexual, and other men who have sex with men at three research sites in Kenya.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001847.
    PubMed     Text format     Abstract available


  201. SERRANO A, El Haddad S, Moal F, Prazuck T, et al
    Dysregulation of apoptosis and autophagy gene expression in PBMCs of efficiently treated HIV-infected patients.
    AIDS. 2018 May 3. doi: 10.1097/QAD.0000000000001851.
    PubMed     Text format     Abstract available


  202. JOHNSON WD, O'Leary A, Flores SA
    Per-partner condom effectiveness for men who have receptive sex with HIV-positive men.
    AIDS. 2018 May 1. doi: 10.1097/QAD.0000000000001832.
    PubMed     Text format     Abstract available


    April 2018
  203. MARCUS JL, Volk JE, Snowden JM
    Concerns about a study on sexually transmitted infections after initiation of HIV preexposure prophylaxis.
    AIDS. 2018;32:955-956.
    PubMed     Text format    


  204. THADEN JT, Gandhi M, Okochi H, Hurt CB, et al
    Seroconversion on PrEP: a case report with segmental hair analysis for timed adherence determination.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001825.
    PubMed     Text format     Abstract available


  205. ERON JJ, Orkin C, Gallant J, Molina JM, et al
    A week 48 randomized phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001817.
    PubMed     Text format     Abstract available


  206. LEYES P, Cofan M, Gonzalez-Cordon A, de Lazzari E, et al
    Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor associated hypercholesterolaemia.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001837.
    PubMed     Text format     Abstract available


  207. DUCLOY C, Su B, Mayr L, Klingler J, et al
    HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001834.
    PubMed     Text format     Abstract available


  208. KONERU R, Bimonte-Nelson H, Ciavatta V, Haile W, et al
    Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorders mouse model.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001836.
    PubMed     Text format     Abstract available


  209. DE OLIVEIRA F, Cappy P, Lemee V, Moisan A, et al
    Detection of numerous HIV-1/MO recombinants in France.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001814.
    PubMed     Text format     Abstract available


  210. CHAMIE G, Schaffer EM, Ndyabakira A, Emperador DM, et al
    Comparative effectiveness of novel non-monetary incentives to promote HIV testing: a randomized trial.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001833.
    PubMed     Text format     Abstract available


  211. CUADROS DF, Branscum AJ, Mukandavire Z
    Temporal stability of HIV prevalence in high burden areas regardless of declines in national HIV prevalence in Malawi and Zimbabwe.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001820.
    PubMed     Text format     Abstract available


  212. DEUSCH S, Serrano-Villar S, Rojo D, Martinez-Martinez M, et al
    Effects of HIV, ART and prebiotics on the active fraction of the gut microbiota.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001831.
    PubMed     Text format     Abstract available


  213. JACQUET JM, Peyriere H, Makinson A, Peries M, et al
    Psychoactive substances, alcohol and tobacco consumption in HIV-infected outpatients.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001830.
    PubMed     Text format     Abstract available


  214. ALMEIDA-BRASIL CC, Moodie EEM, Mclinden T, Hamelin AM, et al
    Medication non-adherence, multi-tablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppression.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001822.
    PubMed     Text format     Abstract available


  215. MASABA R, Borkowf CB, Girde S, Zeh C, et al
    Adverse fetal and infant outcomes among HIV-infected women who received either NNRTI- or PI-based ART for PMTCT.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001816.
    PubMed     Text format     Abstract available


  216. GEORGE VK, Pallikkuth S, Pahwa R, de Armas L, et al
    Circulating inflammatory monocytes contribute to impaired influenza vaccine responses in HIV-infected participants.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001821.
    PubMed     Text format     Abstract available


  217. KONG CY, Sigel K, Criss SD, Sheehan DF, et al
    Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ >/= 500: a simulation study.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001818.
    PubMed     Text format     Abstract available


  218. OLESEN JS, Jespersen S, Da Silva ZJ, Rodrigues A, et al
    HIV-2 continues to decrease, while HIV-1 is stabilizing in Guinea-Bissau.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001827.
    PubMed     Text format     Abstract available


  219. BULL ME, Mitchell C, Soria J, Styrchak S, et al
    Monotypic low-level HIV viremias during ART are associated with disproportionate production of X4 virions and systemic immune activation.
    AIDS. 2018 Apr 19. doi: 10.1097/QAD.0000000000001824.
    PubMed     Text format     Abstract available


  220. MISSAILIDIS C, Neogi U, Stenvinkel P, Troseid M, et al
    The microbial metabolite TMAO in association with inflammation and microbial dysregulation in three HIV cohorts at various disease stages.
    AIDS. 2018 Apr 3. doi: 10.1097/QAD.0000000000001813.
    PubMed     Text format     Abstract available


  221. CHUNG A, Makuba JM, Ndlovu B, Licht A, et al
    Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    AIDS. 2018 Apr 3. doi: 10.1097/QAD.0000000000001812.
    PubMed     Text format     Abstract available


    March 2018
  222. ROBINSON-PAPP J, Nmashie-Osei A, Pedowitz E, Benn EKT, et al
    Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001802.
    PubMed     Text format     Abstract available


  223. PRESTI RM, Handley S, Droit L, Ghannoum M, et al
    Alterations in the oral microbiome in HIV-infected participants after ART administration are influenced by immune status.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001811.
    PubMed     Text format     Abstract available


  224. WILKINSON JD, Williams PL, Yu W, Colan SD, et al
    Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001810.
    PubMed     Text format     Abstract available


  225. BASTEN M, Heijne JCM, Geskus R, Daas CD, et al
    Sexual risk behaviour trajectories among men who have sex with menat risk for HIV in Amsterdam, the Netherlands: a 10 year follow-up study.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001803.
    PubMed     Text format     Abstract available


  226. MERCHANTE N, Rodriguez-Arrondo F, Revollo B, Merino E, et al
    Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/HCV-coinfected patients.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001809.
    PubMed     Text format     Abstract available


  227. SHI L, Yu L, Zhong D, Gu C, et al
    TMC120 displayed potent cytotoxic effect on human cervical carcinoma through enhancing the polymerization of microtubules.
    AIDS. 2018 Mar 28. doi: 10.1097/QAD.0000000000001808.
    PubMed     Text format     Abstract available


  228. DEHGHAN MANSHADI SA, SeyedAlinaghi S, Mousavi SA, Salehi MR, et al
    John Cunningham virus large T antigen detection in brain biopsy of an HIV-infected patient with glioblastoma multiforme: more than a coincidental finding.
    AIDS. 2018;32:830-833.
    PubMed     Text format    


  229. SORTINO O, Richards E, Dias J, Leeansyah E, et al
    IL-7 treatment supports CD8+ mucosa-associated invariant T-cell restoration in HIV-1-infected patients on antiretroviral therapy.
    AIDS. 2018;32:825-828.
    PubMed     Text format     Abstract available


  230. JUSTICE AC, Gordon KS, Skanderson M, Edelman EJ, et al
    Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.
    AIDS. 2018;32:739-749.
    PubMed     Text format     Abstract available


  231. VALENCIA J, Ryan P, Alvaro-Meca A, Troya J, et al
    High HIV seroconversion rate in HCV-infected drug users followed in a Harm Reduction Unit: A lost opportunity for Pre- exposure Prophylaxis.
    AIDS. 2018 Mar 20. doi: 10.1097/QAD.0000000000001806.
    PubMed     Text format     Abstract available


  232. PALELLA F JR, Li X, Gupta SK, Estrella MM, et al
    Long-term kidney function, proteinuria, and associated risks among HIV-infected and uninfected men.
    AIDS. 2018 Mar 20. doi: 10.1097/QAD.0000000000001807.
    PubMed     Text format     Abstract available


  233. KROEZE S, Ondoa P, Kityo CM, Siwale M, et al
    Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001801.
    PubMed     Text format     Abstract available


  234. DIJKSTRA M, Van Lunsen RHW, Kooij KW, Davidovich U, et al
    HIV-1 status is independently associated with decreased erectile function among middle-aged men who have sex with men in the era of cART.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001800.
    PubMed     Text format     Abstract available


  235. CHOW FC, Wilson MR, Wu K, Ellis RJ, et al
    Stroke incidence is highest in women and non-Hispanic Blacks living with HIV in the ALLRT cohort.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001799.
    PubMed     Text format     Abstract available


  236. AZIZ SAA, Mcstea M, Bashah NSA, Chong ML, et al
    Assessment of sarcopenia in virally suppressed HIV-infected Asians receiving treatment.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001798.
    PubMed     Text format     Abstract available


  237. TARANCON-DIEZ L, Pablo-Bernal RS, Jimenez JL, Alvarez-Rios AI, et al
    Role of TLR4 Asp299Gly polymorphism in the development of cardiovascular diseases in HIV-infected patients.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001797.
    PubMed     Text format     Abstract available


  238. THAKUR KT, Boubour A, Saylor D, Das M, et al
    Global HIV neurology: a comprehensive review.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001796.
    PubMed     Text format     Abstract available


  239. GARCIA-PAYA E, Fernandez M, Padilla S, Garcia JA, et al
    High-grade anal intraepithelial neoplasia is associated with HIV-1 RNA rectal shedding in virologically suppressed men who have sex with men.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001794.
    PubMed     Text format     Abstract available


  240. CLUVER L, Meinck F, Toska E, Orkin FM, et al
    Multi-type violence exposures and adolescent antiretroviral non-adherence in South Africa.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001795.
    PubMed     Text format     Abstract available


  241. MEYER-RATH G, McGillen JB, Cuadros DF, Hallett TB, et al
    Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV programme planning.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001792.
    PubMed     Text format    


  242. ALESSANDRI-GRADT E, De Oliveira F, Leoz M, Lemee V, et al
    HIV-1 group P infection: towards a dead-end infection?
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001791.
    PubMed     Text format     Abstract available


  243. LINDGREN AA, Filipowicz AR, Hattler JB, Kim SO, et al
    Lentiviral infection of proliferating brain macrophages in SIV and HIV encephalitis despite SAMHD1 expression.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001793.
    PubMed     Text format     Abstract available


  244. CHAUDHURY S, Mayondi GK, Williams PL, Leidner J, et al
    In utero exposure to antiretrovirals and neurodevelopment among HIV-exposed uninfected children in Botswana.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001790.
    PubMed     Text format     Abstract available


  245. ABRAHAM AG, Zhang L, Calkins K, Tin A, et al
    Vitamin D status and immune function reconstitution in HIV-infected men initiating therapy in the Multicenter AIDS cohort study.
    AIDS. 2018 Mar 15. doi: 10.1097/QAD.0000000000001782.
    PubMed     Text format     Abstract available



  246. Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects: Erratum.
    AIDS. 2018;32:685.
    PubMed     Text format    



  247. Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals: Erratum.
    AIDS. 2018;32:681.
    PubMed     Text format    



  248. Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection: Erratum.
    AIDS. 2018;32:679.
    PubMed     Text format    


  249. ISMAIL MF, Wong DK, Bogoch II
    The role for hepatitis A vaccination in HIV pre-exposure prophylaxis.
    AIDS. 2018;32:675-676.
    PubMed     Text format    


  250. POIZOT-MARTIN I, Laroche H, Cano CE, Nicolino-Brunet C, et al
    Cancer risk in HIV-infected patients: elite controllers are also concerned.
    AIDS. 2018;32:673-675.
    PubMed     Text format    


  251. OLDENBURG CE, Chanda MM, Ortblad KF, Mwale M, et al
    Effect of HIV self-testing on the number of sexual partners among female sex workers in Zambia.
    AIDS. 2018;32:645-652.
    PubMed     Text format     Abstract available


    February 2018

  252. Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial: Erratum.
    AIDS. 2018;32:537.
    PubMed     Text format    


  253. COGHILL AE, Schenk JM, Mahkoul Z, Orem J, et al
    Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda.
    AIDS. 2018;32:505-512.
    PubMed     Text format     Abstract available


  254. MCMAHON CN, Petoumenos K, Hesse K, Carr A, et al
    High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years.
    AIDS. 2018;32:451-459.
    PubMed     Text format     Abstract available


  255. MCNULTY MC, Schneider JA
    Care continuum entry interventions: seek and test strategies to engage persons most impacted by HIV within the United States.
    AIDS. 2018;32:407-417.
    PubMed     Text format     Abstract available


  256. O'HALLORAN JA, Dunne E, Tinago W, Denieffe S, et al
    Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet-collagen interactions.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001783.
    PubMed     Text format     Abstract available


  257. MORA-PERIS B, Bouliotis G, Ranjababu K, Clarke A, et al
    Changes in Cerebral Function Parameters with Maraviroc Intensified Antiretroviral Therapy in Treatment Naive HIV-Positive Individuals; A Randomised Controlled Study.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001786.
    PubMed     Text format     Abstract available


  258. MORAN CA, Sheth AN, Mehta CC, Hanna DB, et al
    The association of C-reactive protein with subclinical cardiovascular disease in HIV-infected and HIV-uninfected women.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001785.
    PubMed     Text format     Abstract available


  259. MEDRANO LM, Garcia-Broncano P, Berenguer J, Gonzalez-Garcia J, et al
    Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/HCV-coinfected patients.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001787.
    PubMed     Text format     Abstract available


  260. TABB ZJ, Mmbaga BT, Gandhi M, Louie A, et al
    Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001788.
    PubMed     Text format     Abstract available


  261. PRADAT P, Huleux T, Raffi F, Delobel P, et al
    Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV.
    AIDS. 2018 Feb 12. doi: 10.1097/QAD.0000000000001789.
    PubMed     Text format     Abstract available


  262. WRIGHT EJ, Grund B, Robertson KR, Cysique L, et al
    No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001778.
    PubMed     Text format     Abstract available


  263. GUERRI-FERNANDEZ R, Lerma-Chippirraz E, Fernandez Marron A, Garcia-Giralt N, et al
    Bone density, microarchitecture and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001780.
    PubMed     Text format     Abstract available


  264. LEPIK KJ, Yip B, Ulloa A, Wang L, et al
    Adverse drug reactions to integrase strand transfer inhibitors.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001781.
    PubMed     Text format     Abstract available


  265. WHITE K, Garner W, Wei L, Eron JJ, et al
    Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001779.
    PubMed     Text format     Abstract available


  266. KENNEDY MC, Kerr TH, Wood E, Shoveller JA, et al
    Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001777.
    PubMed     Text format     Abstract available


  267. RIPAMONTI D, Zazzi M
    Rethinking recycling nucleoside reverse transcriptase inhibitors in HIV treatment: learning from the MODIBIP study.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001776.
    PubMed     Text format    


  268. FOURMAN LT, Czerwonka N, Shaikh SD, Stanley TL, et al
    Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001775.
    PubMed     Text format     Abstract available


  269. PALLIKKUTH S, De Armas LR, Pahwa R, Rinaldi S, et al
    Impact of aging and HIV infection on serologic response to seasonal influenza vaccination.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001774.
    PubMed     Text format     Abstract available


  270. WEINBERG A, Huang S, Moscicki AB, Saah A, et al
    Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001773.
    PubMed     Text format     Abstract available


  271. WOOD S, Ratcliffe S, Gowda C, Lee S, et al
    Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001772.
    PubMed     Text format     Abstract available


  272. EPELDEGUI M, Magpantay L, Guo Y, Halec G, et al
    A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001771.
    PubMed     Text format     Abstract available


  273. GANTNER P, Barnig C, Partisani M, Lee GQ, et al
    Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001770.
    PubMed     Text format     Abstract available


  274. MITCHELL KM, Dimitrov D, Hughes JP, Xia F, et al
    In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001766.
    PubMed     Text format     Abstract available


  275. EASTMENT MC, McClelland RS
    Vaginal microbiota and susceptibility to HIV.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001768.
    PubMed     Text format     Abstract available


  276. PATEL CJ, Bhattacharya J, Ioannidis JPA, Bendavid E, et al
    Systematic identification of correlates of HIV infection: an X-wide association study.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001767.
    PubMed     Text format     Abstract available


  277. TITANJI K, Vunnava A, Foster A, Sheth AN, et al
    T-cell receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts.
    AIDS. 2018 Feb 8. doi: 10.1097/QAD.0000000000001764.
    PubMed     Text format     Abstract available


    January 2018
  278. DUNCAN CJA, Charlton FG, Bower M, Price DA, et al
    The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1.
    AIDS. 2018;32:404-406.
    PubMed     Text format    


  279. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients.
    AIDS. 2018;32:337-346.
    PubMed     Text format     Abstract available


  280. LIU G, Sharma M, Tan N, Barnabas R, et al
    HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis.
    AIDS. 2018 Jan 24. doi: 10.1097/QAD.0000000000001765.
    PubMed     Text format     Abstract available


  281. ANDERSSON E, Nordquist A, Esbjornsson J, Flamholc L, et al
    Increase in transmitted drug resistance in migrants from Sub Saharan Africa diagnosed with HIV-1 in Sweden.
    AIDS. 2018 Jan 24. doi: 10.1097/QAD.0000000000001763.
    PubMed     Text format     Abstract available


  282. BILLIOUX VG, Grabowski MK, Ssekasanvu J, Reynolds SJ, et al
    HIV viral suppression and geospatial patterns of HIV antiretroviral therapy treatment facility use in Rakai, Uganda.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001761.
    PubMed     Text format     Abstract available


  283. DEFILIPPI C, Lo J, Christenson R, Grundberg I, et al
    Novel mediators of statin effects on plaque in HIV: a proteomics approach.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001762.
    PubMed     Text format     Abstract available


  284. SORTINO O, Richards E, Dias J, Leeansyah E, et al
    IL-7 treatment supports CD8+ MAIT cell restoration in HIV-1 infected patients on ART.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001760.
    PubMed     Text format     Abstract available


  285. HARGREAVES JR, Krishnaratne S, Mathema H, Lilleston PS, et al
    Individual and community-level risk factors for HIV stigma in 21 Zambian and South African communities: analysis of data from the HPTN071 (PopART) study.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001757.
    PubMed     Text format     Abstract available


  286. THOMSEN D, Erikstrup C, Jespersen S, Medina C, et al
    The influence of HLA-types on disease progression among HIV-2 infected patients in Guinea-Bissau.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001758.
    PubMed     Text format     Abstract available


  287. MULLIGAN N, Best BM, Wang J, Capparelli EV, et al
    Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001755.
    PubMed     Text format     Abstract available


  288. JUSTICE AC, Gordon K, Skanderson M, Edelman EJ, et al
    Non antiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001756.
    PubMed     Text format     Abstract available


  289. DE SILVA TI, Leligdowicz A, Carlson J, Garcia-Knight M, et al
    HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001753.
    PubMed     Text format     Abstract available


  290. CARRICO AW, Cherenack EM, Roach ME, Riley ED, et al
    Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001751.
    PubMed     Text format     Abstract available


  291. SMIT M, Olney J, Ford NP, Vitoria M, et al
    The growing burden of non-communicable disease among persons living with HIV in Zimbabwe.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001754.
    PubMed     Text format     Abstract available


  292. LOGEROT S, Rancez M, Charmeteau-de Muylder B, Figueiredo-Morgado S, et al
    HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001752.
    PubMed     Text format     Abstract available


  293. ROSSI C, Saeed S, Cox J, Vachon ML, et al
    Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients.
    AIDS. 2018 Jan 23. doi: 10.1097/QAD.0000000000001750.
    PubMed     Text format     Abstract available


  294. KOJIMA N, Klausner JD
    Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection.
    AIDS. 2018;32:272-275.
    PubMed     Text format    


  295. ARRANZ-CASO A, Perez-Cruz F, Villa A, Sanz J, et al
    Kaposi sarcoma presenting shortly after primary infection by HIV and human herpesvirus-8.
    AIDS. 2018;32:271-275.
    PubMed     Text format    


  296. MAGGIOLO F, Di Filippo E, Comi L, Callegaro A, et al
    Post treatment controllers after treatment interruption in chronically HIV infected patients.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001743.
    PubMed     Text format     Abstract available


  297. OLDENBURG C, Chanda MM, Ortblad KF, Mwale M, et al
    Effect of HIV self-testing on the number of sexual partners among female sex workers in Zambia: A randomized controlled trial.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001740.
    PubMed     Text format     Abstract available


  298. VELDSMAN KA, Maritz J, Isaacs S, Katusiime MG, et al
    Rapid decline of HIV-1 DNA and RNA in infants starting very early ART may pose a diagnostic challenge.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001739.
    PubMed     Text format     Abstract available


  299. WILLIS SJ, Cole SR, Westreich D, Edmonds A, et al
    Chronic hepatitis C virus infection and subsequent HIV viral load among women with HIV initiating antiretroviral therapy.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001745.
    PubMed     Text format     Abstract available


  300. FU R, Owens DK, Brandeau ML
    Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001747.
    PubMed     Text format     Abstract available


  301. TORRES TS, Harrison LJ, La Rosa AM, Cardoso SW, et al
    Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001738.
    PubMed     Text format     Abstract available


  302. OLDENBURG CE, Bor J, Harling G, Tanser F, et al
    Impact of early antiretroviral therapy eligibility on HIV acquisition: Household-level evidence from rural South Africa.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001737.
    PubMed     Text format     Abstract available


  303. HADDAD L, Wall KM, Kilembe W, Vwailika B, et al
    Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001741.
    PubMed     Text format     Abstract available


  304. CILLO AR, Hong F, Tsai A, Irrinki A, et al
    Blood biomarkers of expressed and inducible HIV-1.
    AIDS. 2018 Jan 13. doi: 10.1097/QAD.0000000000001748.
    PubMed     Text format     Abstract available


  305. BERNARDES C, Russo P, Carvalho D, Saiote J, et al
    Primary HIV infection in a Crohn's disease patient receiving infliximab maintenance therapy.
    AIDS. 2018;32:130-131.
    PubMed     Text format    


  306. YOSHIMURA Y, Miyata N, Komatsu H, Tachikawa N, et al
    Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case.
    AIDS. 2018;32:128-129.
    PubMed     Text format    


  307. CATTANEO D, Rizzardini G, Gervasoni C
    Psychoactive drugs and HIV: are we sure to treat our patients adequately?
    AIDS. 2018;32:127-128.
    PubMed     Text format    


  308. DURAND-ZALESKI I, Mutuon P, Charreau I, Tremblay C, et al
    Costs and benefits of on-demand HIV preexposure prophylaxis in MSM.
    AIDS. 2018;32:95-102.
    PubMed     Text format     Abstract available


    December 2017
  309. RUBINSTEIN PG, Moore PC, Rudek MA, Henry DH, et al
    Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001729.
    PubMed     Text format     Abstract available


  310. RODRIGUEZ-GALLEGO E, Gomez J, Pacheco YM, Peraire J, et al
    A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of ART in HIV-infected patients.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001730.
    PubMed     Text format     Abstract available


  311. NICOLI F, Gallerani E, Sforza F, Finessi V, et al
    The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naive CD4+ T cells.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001734.
    PubMed     Text format     Abstract available


  312. ABECASIS AB, Pingarilho M, Vandamme AM
    Phylogenetic analysis as a forensic tool in HIV transmission investigations: a literature review.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001728.
    PubMed     Text format     Abstract available


  313. GEFFNER ME, Patel K, Jacobson DL, Wu J, et al
    Changes in Insulin Sensitivity over Time and Associated Factors in HIV-Infected Adolescents.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001731.
    PubMed     Text format     Abstract available


  314. LUO M, Czarnecki C, Nebroski M, Kimani J, et al
    KIR3DL1 alleles and their Epistatic Interactions with HLA Class I Influence Resistance and Susceptibility to HIV-1 acquisition in the Pumwani Sex Worker cohort.
    AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001735.
    PubMed     Text format     Abstract available


  315. REIDY WJ, Rabkin M, Syowai M, Schaaf A, et al
    Patient- and program-level monitoring of differentiated service delivery for HIV: a pragmatic and parsimonious approach is needed.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001723.
    PubMed     Text format    


  316. MOUNTFORD J, Octaviana F, Estiasari R, Setiawan DD, et al
    Ex vivo expression of chemokine receptors on cells surrounding cutaneous nerves in patients with HIV-associated sensory neuropathy.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001714.
    PubMed     Text format     Abstract available


  317. NEOGI U, Singh K, Aralaguppe SG, Rogers LC, et al
    Ex vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV-1 non-B subtypes.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001726.
    PubMed     Text format     Abstract available


  318. GAO N, Wang W, Wang C, Gu T, et al
    Development of broad neutralization activity in SHIV-infected rhesus macaques after long-term infection.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001724.
    PubMed     Text format     Abstract available


  319. SADANAND S, Das J, Chung AW, Schoen MK, et al
    Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001716.
    PubMed     Text format     Abstract available


  320. MCCOMSEY GA, Lupo S, Parks D, Poggio MC, et al
    Switch from tenofovir disoproxil fumarate combination to dolutegravir plus rilpivirine improves parameters of bone health.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001725.
    PubMed     Text format     Abstract available


  321. BOSER AS, Bidaud B, Maues S, Guiraud N, et al
    Addressing HIV on the French Guyanese-Brazilian border: no choice but collaboration!
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001727.
    PubMed     Text format    


  322. ALTEKRUSE SF, Shiels MS, Modur SP, Land SR, et al
    Cancer burden attributable to cigarette smoking among HIV-infected people in North America.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001721.
    PubMed     Text format     Abstract available


  323. COGHILL AE, Schenk JM, Mahkoul Z, Orem J, et al
    Omega-3 decreases interleukin-6 levels in HIV and HHV-8 co-infected patients: results from a randomized supplementation trial in Uganda.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001722.
    PubMed     Text format     Abstract available


  324. CORDOVA D, Heinze J, Hsieh HF, Mistry R, et al
    Are trajectories of psychosocial risk in adolescence linked to HIV vulnerability in emerging and young adulthood? an eighteen-year longitudinal study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001717.
    PubMed     Text format     Abstract available


  325. MCMAHON CN, Petoumenos K, Hesse K, Carr A, et al
    Eleven-year incident glucose disorders in treated HIV-infection. The St Vincent's HIV and Diabetes Study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001709.
    PubMed     Text format     Abstract available


  326. NGUYEN VK, Greenwald ZR, Trottier H, Cadieux M, et al
    Incidence of sexually transmitted infections before and after Pre-Exposure Prophylaxis for HIV: a cohort study.
    AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001718.
    PubMed     Text format     Abstract available


    November 2017
  327. MOMPLAISIR FM, Storm D, Nkwihoreze H, Jayeola O, et al
    Improving postpartum retention in care for women living with HIV in the United States.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001707.
    PubMed     Text format     Abstract available


  328. RIZZO MD, Crawford RB, Henriquez JE, Aldhamen Y, et al
    HIV-infected cannabis users have lower circulating CD16+ monocytes and IP-10 levels compared to non-using HIV patients.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001704.
    PubMed     Text format     Abstract available


  329. QIN Y, Han L, Babbitt A, Walker JS, et al
    Experiences using and organizing HIV self-testing: A global qualitative systematic review.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001705.
    PubMed     Text format     Abstract available


  330. FITZPATRICK ME, Kunisaki KM, Morris A
    Pulmonary Disease in HIV-Infected Adults in the Era of Antiretroviral Therapy.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001712.
    PubMed     Text format    


  331. EATON EF, Tamhane A, Davy-Mendez T, Mathews WC, et al
    Trends in ART Prescription, Durability and Modification: New drugs, more changes, but less failure.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001708.
    PubMed     Text format     Abstract available


  332. DOMBLIDES C, Antoine M, Hamard C, Rabbe N, et al
    Non-small cell lung cancer from HIV-infected patients expressed PD-L1 with marked inflammatory infiltrates.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001713.
    PubMed     Text format     Abstract available


  333. LANCKI N, Almirol E, Alon L, McNulty M, et al
    PrEP guidelines have low sensitivity for identifying seroconverters in a sample of Young Black men who have sex with men in Chicago.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001710.
    PubMed     Text format     Abstract available


  334. GRABOWSKI MK, Reynolds S, Kagaayi J, Gray R, et al
    The validity of self-reported antiretroviral use in persons living with HIV: a population-based study.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001706.
    PubMed     Text format     Abstract available


  335. LI F, Ma L, Feng Y, Ruan Y, et al
    HIV-1 and Hepatitis C virus selection bottleneck in Chinese people who inject drugs.
    AIDS. 2017 Nov 30. doi: 10.1097/QAD.0000000000001702.
    PubMed     Text format     Abstract available


  336. XIA Q, Ning Z, Torian LV
    Should we report the proportion of late HIV diagnoses?
    AIDS. 2017;31:2559-2561.
    PubMed     Text format    


  337. WU UI, Hung CC, Chang SY, Jhong YT, et al
    Neutralizing antiinterferon-gamma autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy.
    AIDS. 2017;31:2557-2559.
    PubMed     Text format    


  338. BRENNER BG, Baril JG
    Limiting cardiovascular events associated with HIV and antiretroviral therapy.
    AIDS. 2017;31:2551-2553.
    PubMed     Text format    


  339. DHARAN NJ, Cooper DA
    Reducing medical comorbidities associated with long-term HIV infection: beyond optimizing antiretroviral therapy regimens.
    AIDS. 2017;31:2547-2549.
    PubMed     Text format    


  340. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.
    AIDS. 2017;31:2483-2492.
    PubMed     Text format     Abstract available


  341. MCGILLEN JB, Sharp A, Honermann B, Millett G, et al
    Consequences of a changing US strategy in the global HIV investment landscape.
    AIDS. 2017;31:F19-F23.
    PubMed     Text format     Abstract available


  342. GATELL JM, Assoumou L, Moyle G, Waters L, et al
    Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk.
    AIDS. 2017;31:2503-2514.
    PubMed     Text format     Abstract available



  343. Frailty in HIV infected people: a new risk factor for bone mineral density loss?: Erratum.
    AIDS. 2017;31:2441.
    PubMed     Text format    


  344. SAH P, Fitzpatrick MC, Pandey A, Galvani AP, et al
    HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the 'Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.
    AIDS. 2017;31:2437-2439.
    PubMed     Text format    


  345. DALAL S, Johnson C, Fonner V, Kennedy CE, et al
    Reaching people with undiagnosed HIV infection through assisted partner notification.
    AIDS. 2017;31:2436-2437.
    PubMed     Text format    


  346. JOSEPH DAVEY DL, Wall KM
    Need to include couples' HIV counselling and testing as a strategy to improve HIV partner notification services.
    AIDS. 2017;31:2435-2436.
    PubMed     Text format    


  347. THIEBAUT R, Hue S, Le Marec F, Lelievre JD, et al
    Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.
    AIDS. 2017;31:2355-2365.
    PubMed     Text format     Abstract available


  348. SIEFRIED KJ, Mao L, Cysique LA, Rule J, et al
    Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive ART.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001685.
    PubMed     Text format     Abstract available


  349. LODI S, Gunthard HF, Dunn D, Garcia F, et al
    Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001692.
    PubMed     Text format     Abstract available


  350. MAKINSON A, Hayot M, Eymard-Duvernay S, Ribet C, et al
    HIV is associated with airway obstruction: a matched controlled study.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001691.
    PubMed     Text format     Abstract available


  351. MATHABIRE RUCKER SC, Tayea A, Bitilinyu-Bangoh J, Bermudez-Aza EH, et al
    High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients: results from a cross-sectional survey in Malawi.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001700.
    PubMed     Text format     Abstract available


  352. CHOMONT N, Okoye AA, Favre D, Trautmann L, et al
    Wake me up before you go: A strategy to reduce the latent HIV reservoir.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001695.
    PubMed     Text format     Abstract available


  353. TRIPLETTE M, Justice A, Attia EF, Tate J, et al
    Markers of Chronic Obstructive Pulmonary Disease are associated with mortality in people living with HIV.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001701.
    PubMed     Text format     Abstract available


  354. INZAULE SC, Hamers RL, Calis J, Boerma R, et al
    When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001696.
    PubMed     Text format     Abstract available


  355. FAVARATO G, Townsend CL, Bailey H, Peters H, et al
    Protease inhibitors and preterm delivery: another piece in the puzzle.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001694.
    PubMed     Text format     Abstract available


  356. SHARMA M, Smith JA, Farquhar C, Ying R, et al
    Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya: A mathematical modeling analysis.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001697.
    PubMed     Text format     Abstract available


  357. PONGPIRUL W, Pongpirul K, Ananworanich J, Klinbuayaem V, et al
    Chronic kidney disease incidence and survival of Thai HIV-infected patients.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001698.
    PubMed     Text format     Abstract available


  358. MINGUEZ C, Garcia-Deltoro M, Flores J, Galindo MJ, et al
    Interferon-free therapy for treating HCV in difficult-to-treat HIV-coinfected patients as implemented in routine medical practice.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001699.
    PubMed     Text format     Abstract available


  359. AHMAD F, Mishra N, Ahrenstorf G, Franklin BS, et al
    Evidence of inflammasome activation and formation of monocyte-derived apoptosis-associated speck-like protein containing a caspase-recruitment domain specks in HIV-1 positive patients.
    AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001693.
    PubMed     Text format     Abstract available


  360. MOCROFT A, Laut K, Reiss P, Gatell J, et al
    Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?
    AIDS. 2017 Nov 3. doi: 10.1097/QAD.0000000000001684.
    PubMed     Text format     Abstract available


  361. EDWARDS JK, Cole SR, Hall HI, Mathews WC, et al
    Virologic suppression and CD4 cell count recovery after initiation of raltegravir- or efavirenz- containing HIV treatment regimens.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001668.
    PubMed     Text format     Abstract available


  362. BEIMA-SOFIE K, Wamalwa D, Maleche-Obimbo E, Lingappa JR, et al
    Toll-Like Receptor (TLR) 9 polymorphism is associated with increased Epstein-Barr virus and Cytomegalovirus acquisition in HIV-exposed infants.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001680.
    PubMed     Text format     Abstract available


  363. FORD N, Migone C, Calmy A, Kerschberger B, et al
    Benefits and risks of rapid initiation of antiretroviral therapy: a systematic review and meta-analysis.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001671.
    PubMed     Text format     Abstract available


  364. LAVENDER KJ, Pace C, Sutter K, Messer RJ, et al
    An advanced BLT-humanized mouse model for extended HIV-1 cure studies.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001674.
    PubMed     Text format     Abstract available


  365. NICOL MR, Brewers LM, Kashuba AD, Sykes C, et al
    The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001678.
    PubMed     Text format     Abstract available


  366. BOIVIN MJ, Barlow-Mosha L, Chernoff M, Laughton B, et al
    Neuropsychological performance in African children with HIV enrolled in a multi-site anti-retroviral clinical trial.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001683.
    PubMed     Text format     Abstract available


  367. CID-SILVA P, Margusino-Framinan L, Balboa-Barreiro V, Martin-Herranz I, et al
    Initial treatment response among HIV subtype F infected patients who started antiretroviral therapy based on integrase inhibitors.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001679.
    PubMed     Text format     Abstract available


  368. CARRILLO J, Negredo E, Puig J, Molinos-Albert LM, et al
    Memory B cell dysregulation in HIV-1 infected Individuals.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001686.
    PubMed     Text format     Abstract available


  369. CANIGLIA EC, Zash R, Jacobson DL, Diseko M, et al
    Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001673.
    PubMed     Text format     Abstract available


  370. LONGENECKER CT, Sullivan CE, Morrison J, Hileman CO, et al
    The effects of HIV and smoking on aortic and splenic inflammation.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001682.
    PubMed     Text format     Abstract available


  371. BARDON VF, Mandelbrot L, Duro D, Dussaux C, et al
    Placental transfer of elvitegravir and cobicistat in an Ex Vivo human cotyledon double perfusion model.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001681.
    PubMed     Text format     Abstract available


  372. BURLACU R, Umlauf A, Luca A, Gianella S, et al
    Sex based differences in neurocognitive functioning in HIV infected young adults.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001687.
    PubMed     Text format     Abstract available


  373. ENGELHARD EAN, Smit C, Van Dijk PR, Kuijper TM, et al
    Health-related quality of life of people with HIV: an assessment of patient related factors and comparison with other chronic diseasess.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001672.
    PubMed     Text format     Abstract available


  374. OLSON A, Bannert N, Sonnerborg A, de Mendoza C, et al
    Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort.
    AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001689.
    PubMed     Text format     Abstract available


    October 2017
  375. TARTAGLIA A, Ferrara SM, Sica S, Santantonio T, et al
    Successful treatment with tenofovir alafenamide of a HIV/hepatitis B virus coinfected patient with HIV and hepatitis B virus drug resistance, end-stage renal disease on haemodialysis.
    AIDS. 2017;31:2314-2315.
    PubMed     Text format    


  376. VASE MO, Ludvigsen M, Bendix K, Dutoit SH, et al
    Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma.
    AIDS. 2017;31:2311-2313.
    PubMed     Text format    


  377. SIEGENBEEK VAN HEUKELOM ML, Marra E, de Vries HJC, van der Loeff MFS, et al
    Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?
    AIDS. 2017;31:2295-2301.
    PubMed     Text format     Abstract available


  378. TASSIOPOULOS K, Abdo M, Wu K, Koletar SL, et al
    Frailty is strongly associated with increased risk of recurrent falls among older HIV-infected adults.
    AIDS. 2017;31:2287-2294.
    PubMed     Text format     Abstract available


  379. MIKKELSEN E, Hontelez JAC, Nonvignon J, Amon S, et al
    The costs of HIV treatment and care in Ghana.
    AIDS. 2017;31:2279-2286.
    PubMed     Text format     Abstract available


  380. MENZA TW, Billock R, Samoff E, Eron JJ, et al
    Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.
    AIDS. 2017;31:2235-2244.
    PubMed     Text format     Abstract available


  381. HOORNENBORG E, Krakower DS, Prins M, Mayer KH, et al
    Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries.
    AIDS. 2017;31:2179-2191.
    PubMed     Text format     Abstract available


  382. LEVINSON KL, Riedel DJ, Ojalvo LS, Chan W, et al
    Gynecologic cancer in HIV infected women: treatment and outcomes in a multi-institutional cohort.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001664.
    PubMed     Text format     Abstract available


  383. SABIN CA, Ryom L, d'Arminio Monforte A, Hatleberg CI, et al
    Abacavir use and risk of recurrent myocardial infarction: the D: A: D Study.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001666.
    PubMed     Text format     Abstract available


  384. VICENZI E, Poli G
    Chronically infected T Cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001655.
    PubMed     Text format    


  385. LACOURSE SM, Pavlinac PB, Cranmer LM, Njuguna IN, et al
    Stool Xpert MTB/RIF and urine lipoarabinomannan (LAM) for diagnosing tuberculosis in hospitalized HIV-infected children.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001662.
    PubMed     Text format     Abstract available


  386. CREPAZ N, Tang T, Marks G, Hall HI, et al
    Changes in viral suppression status among HIV patients receiving care: United States, 2014.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001660.
    PubMed     Text format     Abstract available


  387. NISHIJIMA T, Mutoh Y, Kawasaki Y, Tomonari K, et al
    Cumulative exposure of tenofovir disoproxil fumarate is associated with kidney tubulopathy whether it is currently used or discontinued in HIV-infected patients.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001667.
    PubMed     Text format     Abstract available


  388. SANDERS EJ, Price MA, Karita E, Kamali A, et al
    Differences in acute retroviral syndrome by HIV-1 subtype in a multicentre cohort study in Africa.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001659.
    PubMed     Text format     Abstract available


  389. STAFFORD KA, Magder LS, Hungerford LL, Guralnik JM, et al
    Immunologic response to ART by age among treatment-naive patients in sub-Saharan Africa.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001663.
    PubMed     Text format     Abstract available


  390. GOPALAPPA C, Sansom SL, Farnham PG, Chen YH, et al
    Combinations of interventions to achieve a national HIV incidence reduction goal: insights from the agent-based PATH 2.0 model.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001653.
    PubMed     Text format     Abstract available


  391. DURAND-ZALESKI I, Mutuon P, Charreau I, Tremblay C, et al
    Costs and benefits of On-Demand HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men Analysis of the ANRS IPERGAY study with a one-year follow-up.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001658.
    PubMed     Text format     Abstract available


  392. ROCHA C, Duarte J, Borrego P, Calado R, et al
    Potency of HIV-2-specific antibodies increase in direct association with loss of memory B-cells.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001661.
    PubMed     Text format     Abstract available


    September 2017
  393. ZOBOLI F, Ripamonti D, Benatti SV, Comi L, et al
    Autoimmune hepatitis and HIV infection: two case reports and review of the literature.
    AIDS. 2017;31:2172-2175.
    PubMed     Text format    


  394. HYLE EP, Jani IV, Rosettie KL, Wood R, et al
    The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
    AIDS. 2017;31:2135-2145.
    PubMed     Text format     Abstract available


  395. LAKE AC
    Hepatitis B reactivation in a long-term nonprogressor due to nivolumab therapy.
    AIDS. 2017;31:2115-2118.
    PubMed     Text format     Abstract available


  396. GIANELLA S, Chaillon A, Mutlu EA, Engen PA, et al
    Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals.
    AIDS. 2017;31:2059-2067.
    PubMed     Text format     Abstract available


  397. GOURLAY AJ, Pharris AM, Noori T, Supervie V, et al
    Towards standardized definitions for monitoring the continuum of HIV care in Europe.
    AIDS. 2017;31:2053-2058.
    PubMed     Text format    


  398. JAO J, Powis KM, Kirmse B, Yu C, et al
    Lower mitochondrial DNA and altered mitochondrial fuel metabolism in hiv-exposed uninfected infants in cameroon.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001647.
    PubMed     Text format     Abstract available


  399. BESSON C, Lancar R, Prevot S, Algarte-Genin M, et al
    Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern cART era.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001652.
    PubMed     Text format     Abstract available


  400. EWING AC, King CC, Wiener JB, Chasela CS, et al
    Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001641.
    PubMed     Text format     Abstract available


  401. SCHEEPERS C, Chowdhury S, Wright WS, Campbell CT, et al
    Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001643.
    PubMed     Text format     Abstract available


  402. ANGELOVICH TA, Hearps AC, Oda MN, Borja MS, et al
    Dysfunctional HDL from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001642.
    PubMed     Text format     Abstract available


  403. VAN HEUKELOM MLS, Marra E, de Vries HJC, van der Loeff MFS, et al
    Risk factors for anal HSIL in HIV-positive MSM: is targeted screening possible?
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001639.
    PubMed     Text format     Abstract available


  404. CHOW FC, Regan S, Zanni MV, Looby SE, et al
    Elevated ischemic stroke risk among women living with HIV infection.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001650.
    PubMed     Text format     Abstract available


  405. LAKE JE, Li X, Palella FJ Jr, Erlandson KM, et al
    Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001651.
    PubMed     Text format     Abstract available


  406. RODRIGUEZ-HART C, Nowak RG, Musci R, German D, et al
    Pathways from sexual stigma to incident HIV and sexually transmitted infections among Nigerian men who have sex with men.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001637.
    PubMed     Text format     Abstract available


  407. DUQUENNE C, Gimenez S, Guigues A, Viala B, et al
    Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001649.
    PubMed     Text format     Abstract available


  408. THORNTON AC, Jose S, Bhagani S, Chadwick D, et al
    Hepatitis B, hepatitis C and mortality among HIV-positive individuals.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001646.
    PubMed     Text format     Abstract available


  409. MIKULAK J, Oriolo F, Zaghi E, Di Vito C, et al
    Natural Killer cells in HIV-1 infection and therapy.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001645.
    PubMed     Text format     Abstract available


  410. KUNIHOLM MH, Liang H, Anastos K, Gustafson D, et al
    Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001648.
    PubMed     Text format     Abstract available


  411. BALASUBRAMANIAN R, Fowler MG, Dominguez K, Lockman S, et al
    Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.
    AIDS. 2017 Sep 18. doi: 10.1097/QAD.0000000000001640.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: